Amgen (AMGN)

24,999.000 +934.000 (+3.88%)
Delayed Data ARS Disclaimer
Day's Range
24,065.000 - 25,000.000
52 wk Range
8448.000 - 29000.000
Prev. Close
24,065.000
Open
24,065.000
Volume
25
Average Vol.(3m)
605
1-Year Change
154.41%
Market Cap
52.72T
Beta
0.582
P/E Ratio
19.17
Type
Equity
Market
Argentina
ISIN
ARDEUT110665
CUSIP
-
Shares Outstanding
535,178,027
Revenue
26.83B
EPS
14.14
Dividend (Yield)
0.852 (1.29%)
Next Earnings Date
-
Strong Sell Strong Buy Sell Neutral Buy
Strong Buy
How do you feel today about Amgen Inc?
or

Amgen News & Analysis

  • © Reuters.  sizes=

    Analog Devices earnings, Revenue beat in Q3

    Investing.com - Analog Devices (NASDAQ:ADI) reported on Wednesday third quarter {{erl-7869||earnings that beat analysts' forecasts and revenue that topped expectations. Analog Devices...

    • Investing.com
  • © Reuters.  sizes=

    TJX earnings beat, Revenue misses in Q2

    Investing.com - TJX (NYSE:TJX) reported on Wednesday second quarter {{erl-8227||earnings that beat analysts' forecasts and revenue that fell short of expectations. TJX announced earnings...

    • Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles